1-866-429-3700 BROWSE STUDIES CONTACT US DRUG DEVELOPMENT LABCORP.COM
/content/dam/covance/Images/Labcorp_Logo_Color_RGB.png
  • Browse Studies
  • New to Research
    • New to Research
    • Back
    • Phase I Studies
    • AME studies
  • What to Expect
    • What to Expect
    • Back
    • Will I be Paid for Clinical Trials?
    • Clinical Trial Visit Checklist - Things To Remember
    • Participant's Guide
    • Clinical Trial Questions
  • Locations
    • Locations
    • Back
    • Dallas, TX
    • Daytona Beach, FL
    • Madison, WI
  • Refer A Friend
  • Contact
  • About Us
  • 1-866-429-3700
  • BROWSE STUDIES
  • CONTACT US
  • DRUG DEVELOPMENT
  • LABCORP.COM
<
Browse StudiesNew to ResearchWhat to ExpectLocationsRefer A FriendContactAbout Us
>
  • Phase I Studies
  • AME studies
  • Will I be Paid for Clinical Trials? Clinical Trial Visit Checklist - Things To Remember Participant's Guide Clinical Trial Questions
  • Dallas, TX
  • Daytona Beach, FL
  • Madison, WI
Home /  Browse Studies

Search For Paid Medical Studies

Find the clinical study that's right for you:

Start Date
End Date
Browse Studies

Results

Grid List
  • Title
  • Dates
  • Gender
  • Age
  • Location
  • Compensation
  • Healthy Non-Smoking Males and Females of Non-Childbearing Potential, age 18-65 needed. 8480-232

    Healthy Non-Smoking Males and Females of Non-Childbearing Potential, age 18-65 needed.

    Study Number

    8480-232

    Group

    2

    Gender

    both

    Age

    18 - 65

    Location

    Daytona Beach, Florida

    Compensation

    $4,881

    Study Dates

    Mar. 13 - 31, 2023

    Additional Information

    This is a research study for an investigational drug being developed for the treatment of certain types of cancer.

    The purpose of this study is to look at how much of the study drug enters the circulation of the body when given as a tablet compared to a capsule formulation. The study will measure how much of the study drug gets into the blood and how long the body takes to get rid of it. The study will also evaluate the side effects of the study drug.

     

    Labcorp Daytona Beach, FL is recruiting for:

    - Healthy Non-Smoking Males and Females of Non-Childbearing Potential, age 18-65

    - Body Mass Index between 18-32

    - Study involves 1 stay of 12 nights, plus 1 follow-up call

    - Compensation up to $4,881 may be provided for time and participation 

    Details

    Call Now to Schedule Your Screening Appointment! 

    Check-in: Mar 13
    Check-out: Mar 25

    Follow up Visit: Mar 31

  • Mar. 13 - 31, 2023
  • both
  • Age: 18 to 65
  • Daytona Beach, Florida
  • Compensation: $4,881
  • Healthy Adults, age 18-65 needed. 8499-240 7

    Healthy Adults, age 18-65 needed.

    Study Number

    8499-240 7

    Group

    7

    Gender

    both

    Age

    18 - 65

    Location

    Daytona Beach, Florida

    Compensation

    $7,802

    Study Dates

    Feb. 01 - Apr. 27, 2023

    Additional Information

    The study drug is an investigational drug being developed for the potential treatment of autoimmune diseases (a condition in which the immune system mistakenly attacks the body). 

    The purposes of this study are to evaluate how much of the study drug enters the circulation of the body when given as a new test solution formulation of the study drug compared to the original reference solution formulation of the study drug after subcutaneous (under the skin) injections using a prefilled syringe. The safety and tolerability of the test formulation of the study drug compared to the reference formulation of the study drug.

    The study drug will be given as two separate injections using a prefilled syringe by inserting a needle just under the surface of your skin. You will be randomly assigned to a dose group to receive injections either in both arms, both thighs, or both sides of the lower abdomen.

    Labcorp Daytona Beach, FL is recruiting for:

    - Healthy Adults, age 18-65

    - Body Mass Index between 18-34

    - Study involves 1 stay of 1 night, plus 11 follow-up visits and 3 phone calls

    - Compensation up to $7,802 may be provided for time and participation

     

    Details

    Call Now to Schedule Your Screening Appointment! 

    Group 7: 

    Check-in: Feb 13
    Check-out: Feb 14

    Follow up Visits: Feb 16, 18, 21, 24, 28, Mar 7, 14, 28, Apr 11, 25, May 9

    Phone Calls: Mar 21, Apr 4, 18

  • Feb. 01 - Apr. 27, 2023
  • both
  • Age: 18 to 65
  • Daytona Beach, Florida
  • Compensation: $7,802
  • 2 stays of 10 Nights & 1 Follow up! 8491-081 2a

    2 stays of 10 Nights & 1 Follow up!

    Study Number

    8491-081 2a

    Group

    2a

    Gender

    both

    Age

    18 - 65

    Location

    Daytona Beach, Florida

    Compensation

    $10,305

    Study Dates

    Mar. 20 - May 11, 2023

    Additional Information

    The investigational drug in this research study is being developed for the treatment of certain cancers. The purpose of this part of the study is to evaluate the new tablet formulation of the study drug with and without food.

    Labcorp Daytona Beach, FL is recruiting for:

    - Healthy Non-Smoking Men and Women of Non-Childbearing Potential, age 18-65

    - Body Mass Index between 18-32

    - Study involves 2 separate stays of 10 nights, plus 1 follow-up visit

    - Compensation up to $10,305 may be provided for time and participation

    - Receive up to $300 per qualified participant

    Details

    Call Now to Schedule Your Screening Appointment! 

    Check-in: Mar 20
    Check-out: Mar 30

    Check-in: Apr 12
    Check-out: Apr 22

    Follow Up Visit: May 11

  • Mar. 20 - May 11, 2023
  • both
  • Age: 18 to 65
  • Daytona Beach, Florida
  • Compensation: $10,305
  • 1 Stay of 3 nights & 1 follow-up visit. 8495-334

    1 Stay of 3 nights & 1 follow-up visit.

    Study Number

    8495-334

    Group

    A1a

    Gender

    both

    Age

    18 - 60

    Location

    Dallas, Texas

    Compensation

    $3,150

    Study Dates

    Mar. 07 - 17, 2023

    Additional Information

    Labcorp Dallas, TX is recruiting for:

    - Healthy Adults, age 18-60

    - Body Mass Index between 18-32

    - Study involves 1 stay of 3 nights, plus 1 follow-up visit

    - Compensation up to $3,150 may be provided for time and participation

    - Receive up to $250 per qualified participant

    Details

    The purpose of part A is to evaluate the safety and tolerability (side effects) of the study drug, how much of the study drug and its breakdown products get into the blood stream and urine and how long it takes the body to get rid of them. During your stay, you will be given a single, oral dose of the study drug or placebo (inactive drug) at increasing dose levels.

    Depending on the group you are in, you will be dosing in a fasted or fed state.

    Call Now to Schedule Your Screening Appointment!

     

    Group A1a:

    Check-in: March 7
    Check-out: March 10

    Follow up Visit: March 17

     

    OR

     

    Group A1b:

    Check-in: March 8
    Check-out: March 11

    Follow up Visit: March 18

     

     

  • Mar. 07 - 17, 2023
  • both
  • Age: 18 to 60
  • Dallas, Texas
  • Compensation: $3,150
  • Healthy Non-Smoking Males and Females of Non-Childbearing Potential, age 18-65 needed. 8480-232

    Healthy Non-Smoking Males and Females of Non-Childbearing Potential, age 18-65 needed.

    Study Number

    8480-232

    Group

    1

    Gender

    both

    Age

    18 - 65

    Location

    Dallas, Texas

    Compensation

    $4,881

    Study Dates

    Mar. 06 - 24, 2023

    Additional Information

    Labcorp Dallas, TX is recruiting for:

    - Healthy Non-Smoking Males and Females of Non-Childbearing Potential, age 18-65

    - Body Mass Index between 18-32

    - Study involves 1 stay of 12 nights, plus 1 follow-up call

    - Compensation up to $4,881 may be provided for time and participation

    - Receive up to $200 per qualified participant

    Details

    The purpose of this study is to look at how much of the study drug enters the circulation of the body when given as a tablet compared to a capsule formulation. The study will also evaluate the effect food has on how much of the tablet form of the study drug gets into the bloodstream and how long it takes the body to get rid of it, and to collect information on any side effects that may occur when the tablet form of the study drug is taken with food and without food. The study will also assess the safety and tolerability (side effects) of the study drugs.

    Call Now to Schedule Your Screening Appointment!

     

    Group 1:

    Check-in: March 6
    Check-out: March 18

    Follow up Call: March 24

    OR

    Group 3:

    Check-in: March 20
    Check-out: April 1

    Follow up Call: April 7

     

  • Mar. 06 - 24, 2023
  • both
  • Age: 18 to 65
  • Dallas, Texas
  • Compensation: $4,881
  • Healthy Overweight Adults, age 18-65 needed. 8486-900 M5a

    Healthy Overweight Adults, age 18-65 needed.

    Study Number

    8486-900 M5a

    Group

    M5a

    Gender

    both

    Age

    18 - 65

    Location

    Daytona Beach, Florida

    Compensation

    $18,802

    Study Dates

    Apr. 03 - Aug. 30, 2023

    Additional Information

    The investigational drug being developed for the potential treatment of obesity. This is the first time the study drug will be given to humans. 

     The purpose of Part B is to evaluate safety, tolerability, how much of the study drug gets into the bloodstream and how long the body takes to get rid of it. The effect of the study drug on body weight and appetite following multiple doses will also be evaluated. 

     

    Labcorp Daytona Beach is recruiting for:

    - Healthy Overweight Adults, age 18-65

    - Women must be of non-childbearing potential

    - Body Mass Index between 27-40

    - Study involves 12 separate stays totaling 19 nights and 6 follow-up visits

    - Compensation up to $18,802 may be provided for time and participation

    Details

    Call Now to Schedule Your Screening Appointment!

    Check-in: Apr 3
    Check-out: Apr 8 

    Check-in: Apr 11
    Check-out: Apr 12

    Check-in: Apr 18
    Check-out: Apr 19

    Check-in: Apr 25
    Check-out: Apr 26

    Check-in: May 2
    Checkout: May 3

    Check-in: May 9
    Check-out: May 10

    Check-in: May 16
    Check-out: May 17

    Check-in: May 23
    Check-out: May 24

    Check-in: May 30
    Check-out: May 31

    Check-in: Jun 6
    Check-out: Jun 7

    Check-in: Jun 13
    Check-out: Jun 14

    Check-in: Jun 20
    Check-out: Jun 24

    Follow up Visits: Jun 28, Jul 5, 19, Aug 2, 16 & 30   

  • Apr. 03 - Aug. 30, 2023
  • both
  • Age: 18 to 65
  • Daytona Beach, Florida
  • Compensation: $18,802
  • Healthy Overweight Adults, age 18-65 needed. 8486-900 M5c

    Healthy Overweight Adults, age 18-65 needed.

    Study Number

    8486-900 M5c

    Group

    M5c

    Gender

    both

    Age

    18 - 65

    Location

    Dallas, Texas

    Compensation

    $18,802

    Study Dates

    Apr. 05 - Sep. 01, 2023

    Additional Information

    Labcorp Dallas, TX is recruiting for:

    - Healthy Overweight Adults, age 18-65

    - Women must be of non-childbearing potential

    - Body Mass Index between 27-40

    - Study involves 12 separate stays totaling 19 nights and 6 follow-up visits

    - Compensation up to $18,802 may be provided for time and participation

    Details

    Call Now to Schedule Your Screening Appointment!

    Check-in: Apr 5
    Check-out: Apr 10

    Check-in: Apr 13
    Check-out: Apr 14

    Check-in: Apr 20
    Check-out: Apr 21

    Check-in: Apr 27
    Check-out: Apr 28

    Check-in: May 4
    Checkout: May 5

    Check-in: May 11
    Check-out: May 12

    Check-in: May 18
    Check-out: May 19

    Check-in: May 25
    Check-out: May 26

    Check-in: Jun 1
    Check-out: Jun 2

    Check-in: Jun 8
    Check-out: Jun 9

    Check-in: Jun 15
    Check-out: Jun 16

    Check-in: Jun 22
    Check-out: Jun 26

    Follow up Visits:  Jun, 30, Jul, 7, 21, Aug, 4, 18, Sep, 1 

  • Apr. 05 - Sep. 01, 2023
  • both
  • Age: 18 to 65
  • Dallas, Texas
  • Compensation: $18,802
  • Healthy Non-Smoking Sterile Adults, age 18-65 needed. 8477-862 E4

    Healthy Non-Smoking Sterile Adults, age 18-65 needed.

    Study Number

    8477-862 E4

    Group

    E4

    Gender

    both

    Age

    18 - 65

    Location

    Dallas, Texas

    Compensation

    $15,990

    Study Dates

    Feb. 13 - Apr. 11, 2023

    Additional Information

    Labcorp Dallas, TX is recruiting for:

    - Healthy Non-Smoking Sterile Adults, age 18-65

    - Body Mass Index between 18-32

    - Study involves 2 separate stays totaling 40 nights, plus 3 follow-up visits

    - Compensation up to $15,990 may be provided for time and participation

    - Receive up to $400 per qualified participant

    *Sterile Adults- Males with vasectomy or females of non-childbearing potential

    Details

    Call Now to Schedule Your Screening Appointment!

    E4:

    Check-in: Feb, 13, Mar 4,

    Check-out: Feb 23, Apr 3

    Follow up Visit: Feb 28, Apr 8, 11

  • Feb. 13 - Apr. 11, 2023
  • both
  • Age: 18 to 65
  • Dallas, Texas
  • Compensation: $15,990
  • Healthy Adults, age 18-45 needed. 8501-166

    Healthy Adults, age 18-45 needed.

    Study Number

    8501-166

    Group

    A3c

    Gender

    both

    Age

    18 - 45

    Location

    Dallas, Texas

    Compensation

    $5,970

    Study Dates

    Mar. 08 - Apr. 07, 2023

    Additional Information

    Labcorp Dallas, TX is recruiting for:

    - Healthy Adults, age 18-45

    - Body Mass Index between 18-30

    - Study involves 1 stay of 7 nights, plus 1 follow-up visit

    - Compensation up to $5,970 may be provided for time and participation

    - Receive up to $300 per qualified participant

     

    Details

    The purpose of Part A is to evaluate how much of the study drug gets into the bloodstream and urine, how long the body takes to get rid of it, and the safety and tolerability (side effects) of the study drug when given as a single dose. The effect the study drug has on how your heart pumps blood and its effect on heart rhythm will also be evaluated.

    Call Now to Schedule Your Screening Appointment!

    A3c:

    Check-in: Mar 8

    Check-out: Mar 15

    Follow up Visit: Apr 7

    A3d:

    Check-in: Mar 13

    Check-out: Mar 20

    Follow up Visit: Apr 12

  • Mar. 08 - Apr. 07, 2023
  • both
  • Age: 18 to 45
  • Dallas, Texas
  • Compensation: $5,970
  • Healthy Adults, age 18-60 needed. 8488-062 SAD 3a OR 3b

    Healthy Adults, age 18-60 needed.

    Study Number

    8488-062 SAD 3a OR 3b

    Group

    3a OR 3b

    Gender

    both

    Age

    18 - 60

    Location

    Madison, Wisconsin

    Compensation

    $10,328

    Study Dates

    Feb. 12 - May 31, 2023

    Additional Information

    Labcorp Madison, WI is recruiting for:

    - Healthy Adults, age 18-60

    - Body Mass Index between 18-32

    -Study involves 1 stay of 8 nights, plus 7 follow-up visits

    - Compensation up to $10,328 may be provided for time and participation - Receive up to $300 per qualified participant

    Details

    Call now to schedule your appointment. 

    3a

    Check-in: Feb 12

    Check-out: Feb 20

    OPV: Feb 27, Mar 6, Mar 13, Mar 27, Apr 10, May 8, May 29

    3b

    Check-in: Feb 14

    Check-out: Feb 22

    OPV: Mar 1, Mar 8, Mar 15, Mar 29, Apr 12, May 10, May 31

  • Feb. 12 - May 31, 2023
  • both
  • Age: 18 to 60
  • Madison, Wisconsin
  • Compensation: $10,328
  • 2 stays of 10 nights & 5 OPVs 8472-370 3d

    2 stays of 10 nights & 5 OPVs

    Study Number

    8472-370 3d

    Group

    3d

    Gender

    both

    Age

    40 - 65

    Location

    Dallas, Texas

    Compensation

    $11,744

    Study Dates

    Feb. 12 - Mar. 27, 2023

    Additional Information

    The investigational drug in this research study is being developed for the treatment of breast cancer.

    Labcorp Dallas, TX is recruiting for:

    - Healthy Non-Smoking Males and Females of Non-Childbearing Potential, age 40-65

    - Body Mass Index between 18-32

    - Study involves 2 stays of 10 nights and 5 follow-up visits

    - Compensation up to $11,744 may be provided for time and participation

    - Receive up to $350 per qualified participant

    Details

    The purpose of Cohort 3 of this study is to measure how much of the study drug gets into the bloodstream, and how long it takes the body to get rid of it.

    Group 3d:

    Check-In: Feb 12, Mar 5

    Check-Out: Feb 22, Mar 15

    Outpatient Visit : Feb 27, Mar, 3, 20, 24, 27

     

    OR

    Group 3g:

    Check-In: Feb 23, Mar 16

    Check-Out: Mar 5, Mar 26

    Outpatient Visit : Mar, 10, 14, 31, Apr 4, 7

     

  • Feb. 12 - Mar. 27, 2023
  • both
  • Age: 40 to 65
  • Dallas, Texas
  • Compensation: $11,744
  • 1 Short Stay 8481-177 Grp B ABA

    1 Short Stay

    Study Number

    8481-177 Grp B ABA

    Group

    Group B ABA

    Gender

    male

    Age

    18 - 55

    Location

    Madison, Wisconsin

    Compensation

    $3,330

    Study Dates

    Feb. 15 - 23, 2023

    Additional Information

    This is a research study for an investigational drug being developed for the treatment of Duchenne muscular dystrophy, Becker muscular dystrophy, certain sub-types of limb-girdle muscular dystrophy, and metabolic myopathies.

    This type of study is called a radiolabeled study. The study drug has been specially prepared to contain radiolabeled carbon [14C], a naturally occurring radioactive form of the element carbon. Adding a low dose of radiation to the study drug does not change how the drug works, but helps us to see how the drug appears in the blood, urine, and stool after it is given to you.

    The purpose of Part B of this study is to measure how much of the study drug and its breakdown products get into the bloodstream, urine, and/or stool, and how long it takes the body to get rid of them. In addition, the safety and tolerability of the study drug will be evaluated. You will be given a single, oral dose (tablets) of the study drug followed two hours later by a single intravenous (IV) dose over 2 minutes.

    Part B requires one in-clinic confinement of up to 9 days/8 nights. 

    Labcorp Madison, WI is recruiting for:

    - Healthy Males, age 18-55

    - Body Mass Index between 18-32

    - Study involves 1 stay of 8 nights

    - Compensation up to $3,330 may be provided for time and participation

    - Receive up to $200 per qualified participant

    Details

    Check-In: Feb 15, 2023

    Check-Out: Feb 23, 2023

  • Feb. 15 - 23, 2023
  • male
  • Age: 18 to 55
  • Madison, Wisconsin
  • Compensation: $3,330
  • Women ages 18+ currently breastfeeding their newborn needed. 8498-391 G2

    Women ages 18+ currently breastfeeding their newborn needed.

    Study Number

    8498-391 G2

    Group

    2

    Gender

    female

    Age

    18 - 100

    Location

    Madison, Wisconsin

    Compensation

    $5,400

    Study Dates

    Feb. 23 - Mar. 04, 2023

    Additional Information

    The study drug is a drug that has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with insomnia characterized by difficulties with sleep onset and/or sleep maintenance. The use of the study drug in this study is investigational.

    The purpose of this study is to measure how much of the study drug gets into breast milk of healthy lactating women. In addition, the amount of exposure of the study drug to infants through breast milk will be estimated, and the safety and tolerability of the study drug in healthy lactating women will be evaluated.  You will receive a single, oral dose of the study drug. Breast milk will be collected from each breast using a personal electric pump approximately every 4 to 8 hours or as needed.  

    You will be provided an electric breast pump in order to be able to pump milk which can be stored and which is available for the infant while you are participating in the study. Study staff will provide instructions on using the breast pump and storing the breast milk at home. During the study, your infant should be bottle-fed the stored breast milk. You may resume breastfeeding after the study.

    Labcorp Madison, WI is recruiting for:

    -Women ages 18+, currently breastfeeding their newborn

    -Body Mass Index between 18-35

    -Study involves 1 stay of 4 nights, plus 1 follow-up call

    -Compensation up to $5,400 may be provided for time and participation

    -Receive up to $500 per qualified participant

     

    Details

    Details: 

    Check-In: January 29, 2023

    Check-Out: February 2, 2023

    Phone Call:February 7, 2023

  • Feb. 23 - Mar. 04, 2023
  • female
  • Age: 18 to 100
  • Madison, Wisconsin
  • Compensation: $5,400
  • Healthy Overweight Adults, age 18-65 needed. 8486-900 MAD 4d

    Healthy Overweight Adults, age 18-65 needed.

    Study Number

    8486-900 MAD 4d

    Group

    MAD 4d

    Gender

    both

    Age

    18 - 65

    Location

    Madison, Wisconsin

    Compensation

    $18,802

    Study Dates

    Feb. 27 - Jul. 26, 2023

    Additional Information

    Labcorp Madison is recruiting for:

    - Healthy Overweight Adults, age 18-65

    - Women must be of non-childbearing potential

    - Body Mass Index between 27-40

    - Study involves 12 separate stays totaling 19 nights and 6 follow-up visits

    - Compensation up to $18,802 may be provided for time and participation

    Details

    Call Now to Schedule Your Screening Appointment!


    Check-In: Feb 27    
    Check-Out: Mar 4

    Check-In : Mar 7
    Check-Out: Mar 8      

    Check-In: Mar 14    
    Check-Out: Mar 15        

    Check-In: Mar 21
    Check-Out: Mar 22       

    Check-In: Mar 28
    Check-Out: Mar 29          

    Check-In: Apr 4
    Check-Out: Apr 5         

    Check-In: Apr 11
    Check-Out: Apr 12         

    Check-In: Apr 18
    Check-Out: Apr 19       

    Check-In: Apr 25
    Check-Out:Apr 26     

    Check-In: May 2
    Check-Out: May 3        

    Check-In: May 9
    Check-Out: May 10        

    Check-In: May 16
    Check-Out:May 20

     

    Follow up Visit: May 24

    Follow up Visit: May 31

    Follow up Visit: Jun 14

    Follow up Visit: Jun 28

    Follow up Visit: Jul 12

    Follow up Visit: Jul 26   

  • Feb. 27 - Jul. 26, 2023
  • both
  • Age: 18 to 65
  • Madison, Wisconsin
  • Compensation: $18,802
  • Healthy Overweight Males and Females, age 18-55 needed. Females must be of non-childbearing potential. 8411-740

    Healthy Overweight Males and Females, age 18-55 needed. Females must be of non-childbearing potential.

    Study Number

    8411-740

    Group

    SAD A10

    Gender

    both

    Age

    18 - 55

    Location

    Madison, Wisconsin

    Compensation

    $3,697

    Study Dates

    Feb. 20 - Mar. 02, 2023

    Additional Information

    Labcorp Madison, WI is recruiting for:

    - Healthy Overweight Males and Females, age 18-55.

    - Females must be of non-childbearing potential.

    - Body Mass Index between 30-39.9

    - Study involves 1 stay of 6 nights and 2 follow-ups

    - Compensation up to $3,697 may be provided for time and participation

    - Receive up to $500 per qualified participant

    Details

    Details:

    Check-In: Feb 20

    Check-Out: Feb 26

    Outpatient Visit: Feb 28

    Outpatient Visit: Mar 2 

  • Feb. 20 - Mar. 02, 2023
  • both
  • Age: 18 to 55
  • Madison, Wisconsin
  • Compensation: $3,697
Previous
Results 1 - 15 Of ( 15 )
Next

Contact us

CALL US AT 1-866-429-3700
Labcorp logo

Labcorp Clinical Trials is a business segment of Labcorp Inc., a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Labcorp is a registered trademark and the marketing name for Labcorp Inc. and its subsidiaries around the world.

Navigation

Explore

  • Browse Studies
  • Contact Us
  • Locations
  • New to Clinical Research?
  • Refer a Friend

About Us

  • Overview
  • Drug Development
  • Labcorp
  • Copyright © 2023 Labcorp - All rights reserved
  • Privacy Policy
  • Terms of Use
  • Site Map
  • No-Show Policy
Scroll to top